Literature DB >> 23728718

Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue?

Giovanna Calandra-Buonaura1, Pietro Guaraldi, Luisa Sambati, Giovanna Lopane, Annagrazia Cecere, Giorgio Barletta, Federica Provini, Manuela Contin, Paolo Martinelli, Pietro Cortelli.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease characterised by cardiovascular autonomic failure and/or urinary dysfunctions, associated with parkinsonism, cerebellar and/or corticospinal signs, usually leading to death after an average of 7 years. We describe the disease course of five patients diagnosed with probable MSA (4 with predominant parkinsonism and 1 with predominant cerebellar ataxia) who survived for more than 15 years and were followed throughout the disease course at our department. Cardiovascular autonomic dysfunction of any severity occurred late (mean latency from disease onset 9.4 ± 5 years) in this subgroup of MSA patients. The time of involvement of the urogenital system was more variable (from 0 to 14 years after disease onset) and manifested with symptoms of storage disorders (urinary urgency, frequency and incontinence) and erectile dysfunction in men. Conversely complains suggestive of urinary voiding dysfunction (incomplete bladder emptying and urinary retention) were not recorded and patients required catheterization only late in the disease course. In conclusion, our study showed that late onset of both cardiovascular autonomic failure and urinary voiding disorders may be positive prognostic factors in MSA irrespective of the MSA subtype.

Entities:  

Mesh:

Year:  2013        PMID: 23728718     DOI: 10.1007/s10072-013-1470-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it?

Authors:  Takashi Ito; Ryuji Sakakibara; Kosaku Yasuda; Tatsuya Yamamoto; Tomoyuki Uchiyama; Zhi Liu; Tomonori Yamanishi; Yusuke Awa; Kaori Yamamoto; Takamichi Hattori
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

2.  Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch.

Authors:  Igor N Petrovic; Helen Ling; Yasmine Asi; Zeshan Ahmed; Prashanth L Kukkle; Lili-Naz Hazrati; Anthony E Lang; Tamas Revesz; Janice L Holton; Andrew J Lees
Journal:  Mov Disord       Date:  2012-07-17       Impact factor: 10.338

Review 3.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

4.  Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy.

Authors:  Mari Tada; Osamu Onodera; Masayoshi Tada; Tetsutaro Ozawa; Yue-Shan Piao; Akiyoshi Kakita; Hitoshi Takahashi; Masatoyo Nishizawa
Journal:  Arch Neurol       Date:  2007-02

Review 5.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

Authors:  Hirohisa Watanabe; Yufuko Saito; Shinichi Terao; Tetsuo Ando; Teruhiko Kachi; Eiichiro Mukai; Ikuko Aiba; Yuji Abe; Akiko Tamakoshi; Manabu Doyu; Masaaki Hirayama; Gen Sobue
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

6.  Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.

Authors:  Ronald B Postuma; Josie-Anne Bertrand; Jacques Montplaisir; Catherine Desjardins; Mélanie Vendette; Silvia Rios Romenets; Michel Panisset; Jean-François Gagnon
Journal:  Mov Disord       Date:  2012-02-09       Impact factor: 10.338

7.  Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.

Authors:  S S O'Sullivan; L A Massey; D R Williams; L Silveira-Moriyama; P A Kempster; J L Holton; T Revesz; A J Lees
Journal:  Brain       Date:  2008-04-02       Impact factor: 13.501

Review 8.  The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies.

Authors:  A Fanciulli; S Strano; C Colosimo; C Caltagirone; G Spalletta; F E Pontieri
Journal:  Eur J Neurol       Date:  2012-07-27       Impact factor: 6.089

9.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

10.  The natural history of multiple system atrophy: a prospective European cohort study.

Authors:  Gregor K Wenning; Felix Geser; Florian Krismer; Klaus Seppi; Susanne Duerr; Sylvia Boesch; Martin Köllensperger; Georg Goebel; Karl P Pfeiffer; Paolo Barone; Maria Teresa Pellecchia; Niall P Quinn; Vasiliki Koukouni; Clare J Fowler; Anette Schrag; Christopher J Mathias; Nir Giladi; Tanya Gurevich; Erik Dupont; Karen Ostergaard; Christer F Nilsson; Håkan Widner; Wolfgang Oertel; Karla Maria Eggert; Alberto Albanese; Francesca del Sorbo; Eduardo Tolosa; Adriana Cardozo; Günther Deuschl; Helge Hellriegel; Thomas Klockgether; Richard Dodel; Cristina Sampaio; Miguel Coelho; Ruth Djaldetti; Eldad Melamed; Thomas Gasser; Christoph Kamm; Giuseppe Meco; Carlo Colosimo; Olivier Rascol; Wassilios G Meissner; François Tison; Werner Poewe
Journal:  Lancet Neurol       Date:  2013-02-05       Impact factor: 44.182

View more
  8 in total

1.  SPG7: The Great Imitator of MSA-C Within the ILOCAs.

Authors:  Paula Salgado; Anna Latorre; Claudia Del Gamba; Elisa Menozzi; Bettina Balint; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2018-12-06

2.  Comparison of Different Symptom Assessment Scales for Multiple System Atrophy.

Authors:  Masaaki Matsushima; Ichiro Yabe; Koji Oba; Ken Sakushima; Yasunori Mito; Asako Takei; Hideki Houzen; Kazufumi Tsuzaka; Kazuto Yoshida; Yasunori Maruo; Hidenao Sasaki
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

3.  Clinicopathological correlates of pyramidal signs in multiple system atrophy.

Authors:  Chi-Ying R Lin; Anisha Viswanathan; Tiffany X Chen; Hiroshi Mitsumoto; Jean P Vonsattel; Phyllis L Faust; Sheng-Han Kuo
Journal:  Ann Clin Transl Neurol       Date:  2022-05-20       Impact factor: 5.430

4.  Clinical features and autonomic testing predict survival in multiple system atrophy.

Authors:  Elizabeth A Coon; David M Sletten; Mariana D Suarez; Jay N Mandrekar; J Eric Ahlskog; James H Bower; Joseph Y Matsumoto; Michael H Silber; Eduardo E Benarroch; Robert D Fealey; Paola Sandroni; Phillip A Low; Wolfgang Singer
Journal:  Brain       Date:  2015-09-13       Impact factor: 13.501

5.  Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm.

Authors:  Alessandra Fanciulli; Stefano Strano; Jean Pierre Ndayisaba; Georg Goebel; Laura Gioffrè; Massimiliano Rizzo; Carlo Colosimo; Carlo Caltagirone; Werner Poewe; Gregor K Wenning; Francesco E Pontieri
Journal:  J Neurol       Date:  2014-04-16       Impact factor: 4.849

6.  Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study.

Authors:  Tao Yue; Hui Lu; Xiao-Mei Yao; Xia Du; Ling-Ling Wang; Dan-Dan Guo; Yi-Ming Liu
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

7.  Cognitive Profile and Its Evolution in a Cohort of Multiple System Atrophy Patients.

Authors:  Luisa Sambati; Giovanna Calandra-Buonaura; Giulia Giannini; Ilaria Cani; Federica Provini; Roberto Poda; Federico Oppi; Michelangelo Stanzani Maserati; Pietro Cortelli
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

Review 8.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.